In patients with sepsis, hyperglycemia typically arises from the activation of proinflammatory mediators and the release of counterregulatory hormones, resulting in heightened peripheral insulin resistance and increased hepatic gluconeogenesis [39]. The gene discussed is INS; the disease is Sepsis.